Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dornase alfa at ventilation tube insertion for otitis media
ACTRN12623000504617Phase 2Completed
- Sponsor
- Kids Research Institute Australia
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in otitis media, non-suppurative otitis media (OME) and acute otitis media (AOM) comparing Pulmozyme ear with Placebo ear (2 arms). Primary endpoint: Need for repeat ventilation tube insertion due to recurrence of chronic otitis media with effusion. Started May 2012; status: completed.
02
Drugs
dornase alfa
03
Conditions
otitis medianon-suppurative otitis media (OME)acute otitis media (AOM)
Beyond the preview
Go deeper on ACTRN12623000504617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000504617.